InnoCare Optoelectronics (TPE:6861) EBIT: NT$193 Mil (TTM As of Dec. 2025)


TPE:6861 InnoCare Optoelectronics Corp TPE:6861
66 GF Score
Price NT$303.00
GF Value NT$85.66
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is InnoCare Optoelectronics EBIT?

InnoCare Optoelectronics TPE:6861 -9.15% 66 EBIT is NT$193 Mil as of Dec. 2025. GuruFocus rates TPE:6861 with a GF Score™ of 66/100 and a GF Value™ of NT$85.66 (Significantly Overvalued). The stock has 2 warning signs investors should review.

InnoCare Optoelectronics's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2025 was NT$70 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$193 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. InnoCare Optoelectronics's annualized ROC % for the quarter that ended in Dec. 2025 was 13.76%. InnoCare Optoelectronics's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 38.03%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. InnoCare Optoelectronics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 1.62%.


InnoCare Optoelectronics  (TPE:6861) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

InnoCare Optoelectronics's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=160.332 * ( 1 - 21.01% )/( (956.894 + 884.43)/ 2 )
=126.6462468/920.662
=13.76 %

where

Invested Capital(Q: Sep. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2449.354 - 757.574 - ( 734.886 - max(0, 900.288 - 2132.8+734.886))
=956.894

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2578.63 - 825.135 - ( 869.065 - max(0, 974.007 - 2277.979+869.065))
=884.43

Note: The Operating Income data used here is four times the quarterly (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

InnoCare Optoelectronics's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=279.644/( ( (215.486 + max(557.217, 0)) + (199.971 + max(498.156, 0)) )/ 2 )
=279.644/( ( 772.703 + 698.127 )/ 2 )
=279.644/735.415
=38.03 %

where Working Capital is:

Working Capital(Q: Sep. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(789.426 + 540.954 + 33.337) - (757.574 + 0 + 48.926)
=557.217

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(778.394 + 566.649 + 33.604) - (825.135 + 0 + 55.356)
=498.156

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

InnoCare Optoelectronics's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=192.691/11870.824
=1.62 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


InnoCare Optoelectronics EBIT Related Terms


InnoCare Optoelectronics EBIT Historical Data

* Premium members only.

The historical data trend for InnoCare Optoelectronics's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InnoCare Optoelectronics EBIT Chart

InnoCare Optoelectronics Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial 233.86 247.27 130.23 201.14 192.69

InnoCare Optoelectronics Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.36 55.21 27.39 40.18 69.91

TPE:6861 vs ABT, SYK, MDT: EBIT Comparison

For the Medical Devices subindustry, InnoCare Optoelectronics's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InnoCare Optoelectronics EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InnoCare Optoelectronics's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where InnoCare Optoelectronics's EV-to-EBIT falls into.


TPE:6861
66GF Score
InnoCare Optoelectronics Corp TPE:6861
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

InnoCare Optoelectronics EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$193 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of NT$193 Mil mean?
InnoCare Optoelectronics (TPE:6861) has a EBIT of NT$193 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on InnoCare Optoelectronics.
Is InnoCare Optoelectronics' EBIT too high?
InnoCare Optoelectronics' current EBIT is NT$193 Mil. Overall, InnoCare Optoelectronics has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does InnoCare Optoelectronics' EBIT compare to ABT and SYK?
InnoCare Optoelectronics' EBIT of NT$193 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on InnoCare Optoelectronics. InnoCare Optoelectronics's current EBIT is NT$193 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InnoCare Optoelectronics stock overvalued right now?
Based on GuruFocus' analysis, InnoCare Optoelectronics (TPE:6861) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$85.66, compared to a current price of NT$303.00 — trading 253.7% above its estimated fair value. The current EBIT is NT$193 Mil. InnoCare Optoelectronics' overall GF Score™ is 66/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For InnoCare Optoelectronics (TPE:6861), the current EBIT is NT$193 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is InnoCare Optoelectronics (TPE:6861) Overvalued in 2026?

Based on GuruFocus' analysis, InnoCare Optoelectronics stock appears to be overvalued. The current stock price of NT$303.00 is trading 253.7% above its estimated GF Value™ of NT$85.66. GuruFocus considers InnoCare Optoelectronics to be Significantly Overvalued.

Key valuation signals for TPE:6861:

  • EBIT: NT$193 Mil
  • GF Value™: NT$85.66 vs. price of NT$303.00 (253.7% above fair value)
  • GF Score™: 66/100 with 2 warning signs

No single metric tells the full story. See the TPE:6861 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


InnoCare Optoelectronics Business Description

Address Huanxi Road, Room B, No. 2, Section 2, Southern Science Park, Xincheng District, Tainan, TWN, 17571
InnoCare Optoelectronics Corp is mainly engaged in the manufacturing and sale of optical instruments and medical equipment. Its products include X-Ray flat panel detector devices, X-Ray flat panel detector modules, and others.
66GF Score

Get the complete analysis for TPE:6861

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$303.00
Price
NT$85.66
GF Value